|
|
||||||||
Ann Thorac Surg 1999;68:1053-1057
© 1999 The Society of Thoracic Surgeons
a Department of Surgery, St. Louis University Health Sciences Center, St. Louis, Missouri USA
b Departments of Surgery and Pediatrics, University of Virginia Health System, Charlottesville, Virginia, USA
Address reprint requests to Dr Rodgers, Department of Surgery, University of Virginia Health System, PO Box 10005, Charlottesville, VA 22906
e-mail: bmr{at}virginia.edu
Presented at the Forty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Orlando, FL, Nov 1214, 1998.
Abstract
Background. Traditional therapy for refractory chylothorax in the pediatric population has included pleurodesis and thoracic duct ligation. These procedures are associated with high morbidity and questionable success rates.
Methods. We retrospectively reviewed our experience with 15 patients who underwent treatment for chylous effusions using pleuroperitoneal shunts with exteriorized pump chambers. Mean patient age at time of shunt placement was 2.1 (0.1 to 11.5) years and the most common indication (7 of 15) was refractory chylothorax following surgical correction of congenital heart disease. Mean chylothorax duration before shunt placement was 76 (5 to 810) days and shunts were in place for an average of 104 (12 to 365) days. A total of 19 chylous effusions (pleural or pericardial) were treated with shunts.
Results. Nine of 11 right-sided chylothoraces, 5 of 6 left-sided chylothoraces, and 2 of 2 chylopericardia resolved with shunt therapy (84% total). Pleuroperitoneal shunting failed to clear the effusion in 3 children. There were six episodes of shunt malfunction that were repaired and two episodes of infection. Inguinal or umbilical hernia developed in 4 patients.
Conclusions. Externalized pleuroperitoneal shunting is a safe, effective, and minimally invasive treatment for children with refractory chylous effusions.
This article has been cited by other articles:
![]() |
D. A. Cozzi, A. Zani, G. d'Ambrosio, A. Pisera, M. Roggini, and F. Cozzi One-Stage Excision of Massive Cervicomediastinal Lymphangioma in the Newborn Ann. Thorac. Surg., September 1, 2007; 84(3): 1027 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Nair, M. Petko, and M. P. Hayward Aetiology and management of chylothorax in adults Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 362 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-y. Chan, W. Lau, W. H.S. Wong, L.-c. Cheng, A. K.T. Chau, and Y.-f. Cheung Chylothorax in Children After Congenital Heart Surgery Ann. Thorac. Surg., November 1, 2006; 82(5): 1650 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Gomez-Caro, F. J Moradiellos Diez, C. F Marron, E. J Larru Cabrero, and J. L Martin de Nicolas Conservative Management of Postsurgical Chylothorax with Octreotide Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 222 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis and R. M. Sade The Southern Thoracic Surgical Association 50th anniversary celebration: the impact of STSA pediatric cardiothoracic surgery manuscripts on surgical practice Ann. Thorac. Surg., November 1, 2003; 76(90050): S47 - 67. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |